由于人绒毛膜促性腺激素 (hCG) 具有潜在的提高成绩的作用，因此禁止男性运动员使用。一些在常规兴奋剂检测中 hCG 水平升高的运动员被诊断出患有睾丸癌，这凸显了反兴奋剂筛查在癌症检测中的无意作用。本研究探讨了通过精英运动员的常规反兴奋剂测试偶然发现睾丸癌的情况，旨在提高人们对这些筛查潜在的次要好处的认识。我们分析了过去十年的案例，以证明早期检测如何促进及时的医疗干预，使运动员康复并重返竞技运动。通过这些实例，运动员无意中成为了倡导者，有助于提高公众对这一主题的健康认识。版权所有 © 2024 澳大利亚运动医学协会。由爱思唯尔有限公司出版。保留所有权利。

Human chorionic gonadotrophin (hCG) is prohibited in male athletes due to its potential performance-enhancing effects. Some athletes with elevated hCG levels during routine doping tests have been diagnosed with testicular cancer, highlighting the inadvertent role of anti-doping screening in cancer detection. This study explores the incidental detection of testicular cancer through routine anti-doping tests among elite athletes, aiming to raise awareness about the potential secondary benefits of these screenings. We have analyzed cases from the past decade to demonstrate how early detection has facilitated timely medical interventions, allowing athletes to heal and return to competitive sports. Through these instances, athletes become unintentional advocates, contributing to public health awareness about this topic.Copyright © 2024 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.